HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Seiichiro Fujisawa Selected Research

Toremifene (Fareston)

11/2004Kinetic studies of the radical-scavenging activity of estrogens and antiestrogens.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Seiichiro Fujisawa Research Topics

Disease

13Neoplasms (Cancer)
03/2015 - 01/2002
7Periodontal Diseases (Periodontal Disease)
01/2020 - 02/2005
4Carcinogenesis
03/2019 - 11/2004
4Carcinoma (Carcinomatosis)
10/2006 - 08/2002
3Inflammation (Inflammations)
11/2018 - 02/2005
3Leukemia
11/2005 - 11/2003
2Necrosis
03/2015 - 11/2003
1Bacterial Infections (Bacterial Infection)
01/2020
1Alveolar Bone Loss
11/2018
1Persistent Infection
11/2015
1Chronic Disease (Chronic Diseases)
07/2013
1Periodontitis
01/2012
1Chronic Periodontitis
07/2006
1Leukoplakia
07/2006
1Reperfusion Injury
03/2006
1Adenocarcinoma
03/2004
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2003

Drug/Important Bio-Agent (IBA)

7Butylated Hydroxyanisole (BHA)IBA
03/2015 - 08/2002
5EugenolIBA
02/2009 - 08/2002
4CurcuminIBA
01/2007 - 03/2004
3AntioxidantsIBA
03/2015 - 05/2006
3Butylated Hydroxytoluene (BHT)IBA
03/2015 - 11/2003
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2007 - 01/2005
2Biological ProductsIBA
03/2019 - 03/2006
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
03/2015 - 01/2012
2Free RadicalsIBA
07/2013 - 03/2006
2Fibronectins (Fibronectin)IBA
01/2012 - 02/2005
2NF-kappa B (NF-kB)IBA
01/2012 - 02/2005
22-tert-butyl-4-hydroxyanisoleIBA
07/2006 - 05/2006
2diisoeugenolIBA
11/2005 - 02/2005
2Matrix Metalloproteinases (MMPs)IBA
09/2005 - 09/2004
2Oxygen (Dioxygen)IBA
01/2005 - 03/2004
1Ointments (Pastes)IBA
01/2020
1Tetracycline (Achromycin)FDA LinkGeneric
01/2020
1MethacrylatesIBA
11/2018
1hydroxyethyl methacrylate (HEMA)IBA
11/2018
1ethyl acrylateIBA
11/2018
1AcrylatesIBA
11/2018
1cinnamic acidIBA
11/2018
1methyl cinnamateIBA
11/2018
1CinnamatesIBA
11/2018
1triethylene glycol dimethacrylate (TEGMA)IBA
11/2018
1acrylic acid (acrylate)IBA
11/2018
1cinnamaldehyde (cinnamic aldehyde)FDA Link
11/2018
1FlavonoidsIBA
11/2015
1QuercetinIBA
11/2015
1ResveratrolIBA
05/2015
1PhenolsIBA
03/2015
12,4,6-tri-tert-butylphenolIBA
03/2015
1tributyl phosphate (TBP)IBA
03/2015
1Tocopherols (Tocopherol)IBA
07/2013
1LipopolysaccharidesIBA
01/2012
1MelatoninIBA
01/2012
1CytokinesIBA
01/2012
1Horseradish PeroxidaseIBA
01/2007
1tetrahydrocurcuminIBA
01/2007
1Glutathione (Reduced Glutathione)IBA
01/2007
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
07/2006
1CarbonIBA
03/2006
1creosolIBA
09/2005
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
02/2005
1dehydrodiisoeugenolIBA
02/2005
1TamoxifenFDA LinkGeneric
11/2004
1Diethylstilbestrol (Stilbestrol)FDA Link
11/2004
1Estrogens (Estrogen)FDA Link
11/2004
1EstroneFDA Link
11/2004
1Toremifene (Fareston)FDA Link
11/2004
1Estrogen Receptor Modulators (Antiestrogen)IBA
11/2004
1quinone methideIBA
09/2004
1isoeugenolIBA
03/2004
1Caspase 3 (Caspase-3)IBA
11/2003
12-tert-butyl-4-methylphenolIBA
11/2003
1ferulic acid (sodium ferulate)IBA
09/2002
1AlkaloidsIBA
01/2002
1cepharanthineIBA
01/2002

Therapy/Procedure

1Photochemotherapy (Photodynamic Therapy)
01/2020
1Chemoprevention
01/2006
1Drug Therapy (Chemotherapy)
01/2005